
|Videos|June 11, 2019
Dr. Yoland Catherine Antill on Results of the PHAEDRA Trial
Author(s)Yoland Catherine Antill, MD
Cancer Network spoke with Yoland Catherine Antill, MD, of Cabrini Health, about the phase II PHAEDRA trial, which tested the activity of durvalumab in advanced endometrial cancer according to mismatch repair status.
Advertisement
Cancer Network spoke with Yoland Catherine Antill, MD, of Cabrini Health, about the phase II PHAEDRA trial, which tested the activity of durvalumab in advanced endometrial cancer according to mismatch repair status.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma
2
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
3
Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC
4
Reducing Secondary Diagnostic Delay Through the Breast Clinical Reporting and Data System
5



































